Three-hour postdose cyclosporine level monitoring: less rejection and more nephrotoxicity?
Domínguez
J
J
Department of Urology, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Tomic
A
A
Norambuena
R
R
D016572:Cyclosporine / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D016903:Drug Monitoring / Q000379:methods; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology; D011183:Postoperative Complications / Q000453:epidemiology / Q000517:prevention & control; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine